PHP.L

Primary Health Properties Plc
Primary Health Props - Director/PDMR Shareholding
9th May 2024, 13:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8435N
Primary Health Properties PLC
09 May 2024
 

Primary Health Properties PLC

PDMR dealing

On 8 May 2024, the Remuneration Committee of Primary Health Properties PLC (the "Company" or "PHP") made the following award of nil-cost options under the Company's 2021 Long-term Incentive Plan ("LTIP") to a Person Discharging Managerial Responsibilities ("PDMR"):

PDMR

Number of shares under option

Mark Davies

886,824

 

The number of nil-cost options was calculated by reference to a price of £0.9472, being the average of the closing middle market quotations for the Company's ordinary shares on 7 May 2024, 3 May 2024 and 2 May 2024. 

The nil-cost options will normally vest on the third anniversary of grant, subject to the attainment of performance conditions.  The Remuneration Committee has the discretion to adjust the awards downwards at vesting for malus reasons.  Details of the operation of the LTIP are set out in the Company's 2023 Report and Accounts.

Details of the transaction referenced above are included below in accordance with Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

1

Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")

(a)

Name

Mark Davies

 

2

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

 

Primary Health Properties PLC

(b)

LEI

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of the transaction

Award of nil-cost options over the Company's ordinary shares

 

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

886,824

 

(d)

Aggregated volume price

Single transaction: N/A

 

(e)

Date of transaction

8 May 2024

 

(f)

Place of transaction

n/a

 

 

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk 

 

Further details:

Richard Howell

Chief Financial Officer

Tel: +44 (0) 776 6072 272

Toby Newman

Company Secretary & Chief Legal Officer

Tel: +44 (0) 772 9047 959

David Rydell / Stephanie Whitmore (Buchanan Communications)

Tel: +44 (0) 20 7466 5066


 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDGDURBGDGSC]]>
TwitterFacebookLinkedIn